leukemia
Cancer Studies Seem Replicable
Cancer Studies Seem Replicable
Kerry Grens | Jun 27, 2017
In the latest findings from the Reproducibility Project: Cancer Biology, independent researchers achieve results that mirror those of two earlier papers.
Blood Stem Cells Grown in the Lab
Blood Stem Cells Grown in the Lab
Ashley Yeager | May 17, 2017
Researchers identify transcription factors and environmental conditions necessary to reprogram human and mouse cells into cells that function like hematopoietic stem cells.
Synthetic Bones: A Better Bone-Marrow Transplant?
Synthetic Bones: A Better Bone-Marrow Transplant?
Ashley P. Taylor | May 9, 2017
Artificial bones produce new blood cells in mice, obviating the need for irradiation to kill off resident hematopoietic stem cells in recipients.
Scientists Successfully Transplant Human Leukemia Cells into Mice
Scientists Successfully Transplant Human Leukemia Cells into Mice
Diana Kwon | Apr 1, 2017
While studying the progression of healthy cells into cancerous ones, researchers discover a way to engraft human blood cells into animals.
Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion
Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion
Joshua A. Krisch | Jan 10, 2017
The pharma giant’s purchase of the US firm includes the acquisition of investigative cancer drugs.
Leukemia Under the Lens, 1845
Leukemia Under the Lens, 1845
Jenny Rood | Apr 1, 2015
Alfred Donné’s microscopic daguerreotypes described the cellular symptoms of leukemia for the first time.
Two-Faced RNAs
Two-Faced RNAs
Kerry Grens | Apr 1, 2015
The same microRNAs can have opposing roles in cancer.
IDing Cancer with 3-D Genomics
IDing Cancer with 3-D Genomics
Tracy Vence | May 7, 2014
In a proof-of-principle study, scientists show that the three-dimensional shape of a cancer cell genome can reliably classify subtypes of human leukemia.
Commander of an Immune Flotilla
Commander of an Immune Flotilla
Jef Akst | Apr 1, 2014
With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.
Tumor-Targeting T Cells Engineered
Tumor-Targeting T Cells Engineered
Chris Palmer | Aug 11, 2013
Scientists genetically modify T cells derived from pluripotent stem cells to attack lymphatic tumors.